Trade Summary

2 days ago, ROTHBLATT MARTINE A, serving as Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $514.09 per share, for a total transaction value of $4,883,839.34. Following this transaction, ROTHBLATT MARTINE A now holds 324,443 shares of UTHR.

This sale represents a 2.84% decrease in ROTHBLATT MARTINE A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, September 1, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 2, 2026 at 4:34 PM ET, 1 day after the trade was made.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.